PTPN22 and B-cell chronic lymphocytic leukemia: While the regulation of PTPN22 overexpression in CLL cells was largely unknown, here, we found that targeted inhibition or partial depletion of HSP90 in CLL cells reduced PTPN22 protein levels (Figure 4B) when analyzed the same CLL cell lysates used in Figure 2.